Drug intelligence / Profile preview

salcaprozate sodium

Development stage
Phase 1
Lead developer
Novo Nordisk
Modality
Drug Delivery Systems, Small Molecules
Administration
Oral
01

Overview

Salcaprozate sodium is a synthetic N-acetylated amino acid derivative of salicylic acid, primarily used as an oral absorption promoter and intestinal permeation enhancer for drug formulations, especially for macromolecules and poorly permeable compounds[1][3][5]. It acts as a carrier molecule to enhance the gastrointestinal absorption of active pharmaceutical ingredients (APIs) with low bioavailability, such as insulin, heparin, and vitamin B12[1][6][7]. The mechanism of action is not fully understood but may involve increasing membrane permeability of gastrointestinal epithelial cells through membrane perturbation or fluidization, forming non-covalent complexes with APIs to facilitate transcellular transport, or locally elevating pH to protect co-administered drugs from degradation in the stomach[2][4][6]. Salcaprozate sodium has been granted Generally Recognized As Safe (GRAS) status by the FDA and is approved in at least one oral formulation (Eligen Vitamin B12)[2]. It has been studied extensively in clinical trials as an excipient for improving oral bioavailability of peptide and protein drugs.

Brand names
Eligen Vitamin B12
Other names
sodium 8-(2-hydroxybenzamido)octanoatesalcaprozate sodium [USAN]
02

Targets

PEP (Pepsin)

Beyond the preview

Go deeper on salcaprozate sodium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on salcaprozate sodium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call